Beste Vitamininfusionen Therapeuten in der Türkei - TOP -11 Ärzte

The doctor, who has 12 years of experience, previously worked in aesthetic clinics in Nişantaşı and Bakırköy. The doctor, who also has 2 years of experience as a chief physician, can speak good English and intermediate Kurdish. 

He has certificates approved by the Turkish Ministry of Health in the fields of Mesotherapy, Phytotherapy, Cupping Therapy and Ozone Therapy. 

He is a disciplined, innovative and perfectionist physician. Good communication, focused on patient satisfaction. 

He served as the chairman of the Infection Committee, Quality Unit, Inspection Commission, Facility Security and Patient Safety at the State Hospital.

I am Assoc. Prof. Dr. Esra Ozbasli, a board-certified OB-GYN and Genital Cosmetic Surgeon with over 21 years of experience. My dedication to excellence and patient satisfaction has established our clinic as a trusted destination for women’s health and aesthetic procedures in Nişantaşı, heart of Istanbul.I received my medical degree from Istanbul University Cerrahpaşa Medical Faculty, followed by specialized training in obstetrics and gynecology at Istanbul Zeynep Kamil Women and Children Diseases Training and Research Hospital. After working as an academician at Acıbadem University for 12 years, I became an associate professor there by exhibiting my scientific articles in many respected international scientific journals published in Pubmed. During this period, I trained many medical students and OBGYN specialist colleagues in the field of genital aesthetics surgery, urogyneacology. My advanced training in genital cosmetic surgery provided me with expertise in the latest techniques for enhancing and restoring female genital aesthetics and function. I hold certifications in Genital Aesthetics and Cosmetic Gynecology (Vaginal Rejuvenation), Certificate of da Vinci System Training as a Console Surgeon (since 2013) and the ECFMG certificate for foreign medical graduates. Additionally, I possess advanced-level English proficiency (TOEFL score 600 in 2003), ensuring clear communication with international patients. I have completed an observership in New York University in 2005. 

Specialized Services:

 • Genital Cosmetic Surgery: Labioplasty, hudoplasty, vaginoplasty, lipofilling, PRP therapy, hyaluronic acid filling, hymenoplasty, labia majora plasty, vulvar whitening, G-shot, O-shot, treatment of atrophic vagina, lichen sclerosis, and vaginal laxity.

 • Minimally Invasive Surgery: Laparoscopy, robotic surgery, hysteroscopy for fibroids, endometrioma, endometrial polyps, ovarian cysts, tubal ligation, intrauterine septum resection, abnormal vaginal bleeding, and hysterectomy.

 • Menopause Treatment: Bioidentical hormone therapy for managing menopausal symptoms, mezotherapy and laser for atrophic vagina.

•Urinary incontinence treatment: Sling operations (TOT), hyaluronic acid filling, laser treatments.

• Cervical Dysplasia Diagnosis and Treatment: Co-test, PAP-smear, colposcopy guided biopsy and LEEP conization.

International Patient Services: 

We offer a package service for our foreign patients that includes: 

• Arrangements for flights and hotel stays • Pick-up service from the airport and hotel • Assistance throughout your stay to ensure a smooth and stress-free experience • Sightseeing of Istanbul before the surgery if requested

Why Choose Us: 

• Expertise: With over two decades of specialized experience, I offer advanced surgical techniques and personalized care. 

• Innovation: Utilizing the latest technology in minimally invasive and cosmetic procedures to ensure optimal results.

 • Quality Care: I perform my surgeries in A-class hospitals equipped with advanced technological surgical devices. 

• Compassion: Committed to providing a comfortable, supportive, and private environment for all patients. 

 “As a dermatologist, I am interested in aesthetic, cosmetic procedures and dermatologic surgery. I have improved myself in the trainings, courses and congresses I attended during my residency and specialization period. I want to work in these areas in the position I aim to work.”

Education Status

Başakşehir Çam and Sakura City Hospital, Department of Dermatology, Resident Physician: October 2020 - June 2022 (observer assistant between October 2020 - March 2021)

Department of Dermatology, Kiev Medical University (Ukraine), Resident Physician: March 2018 - March 2021

Kocaeli University Faculty of Medicine: 2009-2015

Kadıköy Anatolian High School: 2004-2009 (1+4 years of normal education)

Tunbridge Wells High School 2005-2006 (2 years, UK)

Private Yüzyıl Işıl Primary School 1997-2004

Work Experience

Sakarya University Training and Research Hospital, Department of Dermatology, Specialist Physician: June 2022 - Currently

Başakşehir Çam and Sakura City Hospital, Department of Dermatology, Resident Physician: October 2020 - June 2022 (observer assistant between October 2020 - March 2021)

International Multi-Profile Clinic (Private Clinic), Dermatology, Kiev, Ukraine 2018 - 2020

Department of Dermatology, Kiev Medical University (Ukraine), Resident Physician: March 2018 - March 2021

Kocaeli, Karamürsel Family Medicine: 2016 - 2018

Gölcükspor Football Club Team Doctor 2016 - 2018

Kocaeli Kartepe Racecourse, Emergency Physician: 2016 - 2018

Kocaeli Gölcük District Health Directorate: 2016

Erzurum Tekman State Hospital, Emergency Department 2015 - 2016

Foreign Language

 English - Advanced

 Russian - Intermediate

Medical aesthetics is a specialized field of medicine that focuses on improving cosmetic appearance through the treatment of conditions including scars, skin laxity, wrinkles, moles, liver spots, excess fat, cellulite, unwanted hair, skin discoloration and spider veins. In Istanbul, Turkey, medical aesthetics encompasses a broad range of non surgical procedures that aim to enhance an individual’s appearance and boost their self confidence.

• Injectables: Including Botox and dermal fillers to reduce the appearance of wrinkles and to plump up the skin.
• Laser Treatments: Utilized for hair removal, skin resurfacing, and to diminish the visibility of scars or pigmentation.
• Skin Rejuvenation: Such as chemical peels, microneedling, and light therapy to improve skin texture and tone.

Published journal articles indexed by SCI, SSCI, and AHCI I. Investigation of the effectiveness of teledermatology in the diagnosis of skin lesions in pediatric patients TaslidereN.,KucukO.S. Revista daAssociacaoMedicaBrasileira (1992),vol.69,no.10,2023 (SCI-Expanded) I . Can a Correct Diagnosis Be Established Using the TeledermatologyMethod? TAŞLIDEREN.,SUKÜÇÜKÖ. ACTADERMATOVENEROLOGICACROATICA,vol.30,no.1,pp.32-39,2022 (SCI-Expanded) I I. Melkersson-Rosenthal syndrome induced by COVID-19: A case report TaşlıdereB.,MehmetajL.,ÖzcanA.B.,GülenB.,TaşlıdereN. AmericanJournalofEmergencyMedicine,vol.41,2021 (SCI-Expanded) IV. Which dermatology patients attend to Dermatology Outpatient Clinics during the SARS-CoV-2 outbreak in Turkey and what happened to them? CENGİZ F.P.,EMİROĞLUN.,BAHALIA.G.,DİZMAND.,TAŞLIDEREN.,AkarslanT.C.,GunesB.,MERTÖ.,KÜÇÜKÖ.S., ONSUNN. DERMATOLOGICTHERAPY,vol.33,no.4,2020 (SCI-Expanded)

Professional Experience:

2017 - 2024: SALTAT CLINIC GÖZTEPE BRANCH, Specialist in Dermatology and Venereology

2014 - 2017: MEMORIAL WELLNESS, Specialist in Dermatology and Venereology

2008 - 2014: PRIVATE ISTANBUL MEDIPOL HOSPITAL, Specialist in Dermatology and Venereology

2006 - 2008: MEDICALPARK BAHÇELİEVLER HOSPITAL, Specialist in Dermatology and Venereology

2003 - 2006: TBV SERVICE HOSPITAL, Specialist in Dermatology and Venereology

1999 - 2003: FIZIKOM AESTHETICS AND LASER CENTER, Specialist in Dermatology and Venereology

Education:

1996 - 1999: HASEKI STATE HOSPITAL - Residency in Dermatology

1989 - 1995: ISTANBUL UNIVERSITY, ISTANBUL FACULTY OF MEDICINE, Medical Doctor Training

Experience:

2017- Private Practice

2017 – Plastic Reconstructive and Aesthetic Surgery Specialist – Aesthetic Plastic Surgery Clinic – Endorphin Center – Istanbul

2016-2017 – Plastic Reconstructive and Aesthetic Surgery Specialist – Bitlis State Hospital

2010-2015 – Plastic Reconstructive and Aesthetic Surgery Clinic – Kartal Training and Research Hospital – Istanbul

2009 – General Practitioner – Çekmeköy Taşdelen Health Center – Istanbul

courses

27-28 September 2013, Prof. Dr. Rıdvan Ege 8. Basic Hand Surgery, Acute Hand Injuries Course, Turkish Hand and Upper Extremity Surgery Association, Ankara University Faculty of Medicine, Ankara

7-11 January 2014, 19th Basic Microsurgery Course, Reconstructive Microsurgery Association, Dr. Lütfi Kırdar Kartal Training and Research Hospital, Istanbul

16-25 January 2014, Experimental Animals Use Course, Yeditepe University Experimental Animals Ethics Committee, Istanbul

VIII. Plastic Surgery School (11-18 April 2015) Akra Barut Hotel, Antalya

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Surgeon Ekrem Keskin was born in 1986 in Istanbul. He completed his education at Istanbul University Cerrahpaşa Faculty of Medicine in 2010, and was awarded the title of Medical Doctor. During his residency training he was instructed in nose, facial and breast aesthetics under the supervision of James Zins, MD and Raffi Gurunluoglu, MD, at Cleveland Clinic Plastic and Reconstructive and Aesthetic Surgery Department, Cleveland, OHIO-USA in 2016. After 5 years of Plastic, Reconstructive and Aesthetic Surgery training, he completed his specialization and became a Plastic and Aesthetic Surgery Specialist.

Professional Summary

Dr. Murat Balanlı is an experienced internal medicine specialist with over 35 years in the field of modern medicine. Since completing his medical education, Dr. Balanlı has continuously expanded his expertise, ultimately embracing a holistic approach to healthcare. Rather than seeing holistic medicine as an alternative, he regards it as an essential extension of conventional treatment that focuses on restoring the unity of mind, body, and spirit. His philosophy, rooted in the idea that medicine is a branch of philosophy, aims to treat not only physical symptoms but also the underlying disruptions to an individual’s overall sense of well-being.

Dr. Balanlı's commitment to lifelong learning, his respect for the arts, and his passion for exploring new perspectives on health have enriched his practice and deepened his connection with patients. His experience includes positions in hospital administration, health institution management, and public health, equipping him with a comprehensive understanding of the healthcare system and patient care at various levels.

*Educational Background

Doctor of Medicine (MD)
Ege University, Faculty of Medicine, 1988

Specialist Training in Internal Medicine
Tepecik Training and Research Hospital, 1994

Master’s Degree in Health Institutions Management
Başkent University, Faculty of Social Sciences, 2012

*Professional Experience

Healthy Living Clinic, Turkey

Founder and Head Practitioner
2014 - Present
Founded and oversees the Healthy Living Clinic, which offers personalized holistic treatment plans to patients. Here, Dr. Balanlı integrates modern medicine with holistic practices, aiming to support patients in achieving both physical health and emotional well-being.

SB Behçet Uz Children's Diseases and Surgery Training and Research Hospital

Hospital Administrator
2015 - 2018
Managed administrative and operational functions at one of Turkey's leading children's hospitals, ensuring high standards of healthcare delivery.

Social Security Institution (SGK), Izmir

Regional Director of Health Affairs
2004 - 2009
Oversaw healthcare services and managed regional health affairs for SGK, contributing to policy-making and service delivery improvements across the region.

Board Member
2009 - 2012
Served on the SGK Board of Directors, actively involved in shaping healthcare policies and advocating for quality, affordable healthcare.

Kayseri Ibn-i Sina Medical Centers

Chief Physician
2003 - 2008
Directed medical services, focusing on the integration of patient-centered care with evidence-based medical practices.

Tokat Niksar State Hospital

Chief Physician
1996
Completed mandatory service as a physician, gaining foundational experience in diverse clinical settings.

*Certifications and Advanced Training

• Neuroanatomy, Neuroelectrophysiology, and Biofeedback
  Completed in Romania
• Biorezonance Medicine and Applications
  Completed in Russia
  Specialized training in biorezonance therapy to support holistic approaches in addressing various chronic and stress-related conditions.

*Key Skills and Expertise

• Internal Medicine
• Holistic Medicine Approaches
• Holistic Wellness Approaches
•  
• Patient-Centered Care
• Biorezonance Therapy
• Health Systems Management
• Hospital and Healthcare Administration

Publications and Contributions

Dr. Balanlı has shared his insights on holistic medicine through articles, presentations, and community health talks, with a focus on bridging modern and holistic approaches. His dedication to sharing knowledge has made him a respected figure in both traditional and holistic medical communities.

Languages

• Turkish (Native)
• English (Fluent)
• Russian (Native)
• Azerbaijani (Fluent)

Hello, I am Fatma Duha Özkılıç. I was born in Antalya in 1994. I completed my undergraduate studies in Health Vocational High School Nursing studies between 2008-2012 and Ankara Gazi University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation between 2015-2019. I was developed by obtaining various certifications such as Manual Therapy Training, Norton School International Lymphedema Certification and Pelvic Floor Physiotherapy Training. Throughout my career, I have discovered the only principle of continuous improvement in the expanding spectrum of education. I have in my body the hard work, theoretical and practical knowledge required in every field of the health sector, the ability of teams, the ability to empathize and many more. My main goals are to minimize the pain and suffering that people experience due to their diseases and to improve their quality of life. Being involved in the improvements of the treatment process increases my commitment to the profession. I think that I will contribute to my profession with my devoted efforts in dealing with patients, whether they are treated or not.